Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs

Medicare

>	Main Page
>	Elderly
>	Medicare Advantage
>	Medicare Health Plan Tracker
>	Medicare/Medicaid Dual Enrollees
>	People with Disabilities
>	Prescription Drugs
>	Retiree Benefits

Women's Health Policy

Entertainment Media Studies

Pulling It Together, From Drew Altman

Kaiser Commission on Medicaid and the Uninsured

Kaiser Polls

Media Fellowships

Barbara Jordan Health Policy Scholars Program

News Media Partnerships

Entertainment Media Partnerships

South Africa

Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs

This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. The analysis is based on a model developed by the Actuarial Research Corporation for the Kaiser Family Foundation. The model generally conforms to the Congressional Budget Office’s assumptions and projections about Medicare drug benefit spending and participation rates for the new benefit and for the low-income subsidy. The report was released at a briefing in Washington on November 22, 2004.

This analysis estimates that 6.9 million beneficiaries are projected to be affected by the coverage gap (the so-called "doughnut hole") in the standard Part D drug benefit. This estimate is based on projected enrollment in Part D plans of 29 million (Congressional Budget Office, July 2004), prior to implementation of the drug benefit and actual enrollment in Part D plans.

News Release

Report and Executive Summary

Materials From the November 22, 2004 Briefing:

Information provided by the Medicare Policy Project
Publish Date: 2004-11-22